Don't really understand this placement scare tactic strategy. I believe a placement is likely, but the company still has plenty of funds to keep them going for at least another 6 months. POH has 740mill shares. At 10c that places them with a marketcap of $74mill. Last time they did a share issue they raised $7mill (in October last year ie ONE year ago). I wouldn't expect them to need to raise any more than that (if they indeed need to). At today's shareprice thats less than a 10% dilution of shares. I expect the shareprice to rise substantially over the enxt 6 months. Therefore the dilution may be significantly less.
I really fail to see how a 10% dilution and yesterday's great announcement - which basically confirms they are shooting for commercialisation within the next 6 to 9 months) - and more imminent announcements, including enhanced product lines in Australia and overseas can change the position of POH to a MORE risky investment.
Yesterday's news was excellent. Not sure how anyone can either claim that there waas nothing new in that announcement. My only guess is lack of English comprehension.
- Forums
- ASX - By Stock
- AVE
- great news
great news, page-31
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.2¢ |
Change
-0.001(33.3%) |
Mkt cap ! $6.338M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.2¢ | $2.565K | 874.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 40547400 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 39021116 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 40547400 | 0.002 |
30 | 74217741 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 39021116 | 27 |
0.004 | 16680899 | 15 |
0.005 | 10825266 | 10 |
0.006 | 10908952 | 10 |
0.007 | 13396103 | 7 |
Last trade - 15.59pm 12/11/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online